VYGR icon

Voyager Therapeutics
VYGR

Overview Fund Activity

52 hedge funds and large institutions have $98.1M invested in Voyager Therapeutics in 2017 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 30 increasing their positions, 8 reducing their positions, and 2 closing their positions.

Holders
52
Holders Change
+5
Holders Change %
+10.64%
% of All Funds
1.3%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
7
Increased
30
Reduced
8
Closed
2
Calls
–
Puts
$45K
Net Calls
-$45K
Net Calls Change
-$45K

Top Buyers

1
CC
1
Casdin Capital
New York
$6.63M
2
DCM
2
DAFNA Capital Management
California
$1.84M
3
BlackRock
3
BlackRock
New York
$5.99M
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$1.35M
5
AGA
5
Altrinsic Global Advisors
Connecticut
$1.61M

Top Sellers

1
PHS
1
PFM Health Sciences
California
$7.64M
2
BCPEM
2
Bain Capital Public Equity Management
Massachusetts
$10.5M
3
JPMorgan Chase & Co
3
JPMorgan Chase & Co
New York
$0
4
PIM
4
Partner Investment Management
California
$147K
5
Morgan Stanley
5
Morgan Stanley
New York
$113K
Name Market Value Shares Shares
Change 		Shares
Change %
Royal Bank of Canada
51
Royal Bank of Canada
Ontario, Canada
$1K 125 -316 -72%
Citigroup
52
Citigroup
New York
$1K 97 +72 +288%
JPMorgan Chase & Co
53
JPMorgan Chase & Co
New York
– – -163,000 Closed
UBS Group
54
UBS Group
Switzerland
– – -745 Closed
SO
55
STRS Ohio
Ohio
– – – –
1 2
3